Explore
Validate
Learn
Immunohistochemistry
Other assayAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA1-25914 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- HLA-DR/DP/DQ Monoclonal Antibody (CR3/43)
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- Recommended positive controls: Tonsil.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- CR3/43
- Vial size
- 1 mL
- Concentration
- Conc. Not Determined
- Storage
- 4° C
Submitted references Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis.
CD103 and Intratumoral Immune Response in Breast Cancer.
Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer.
Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer.
Smillie CS, Biton M, Ordovas-Montanes J, Sullivan KM, Burgin G, Graham DB, Herbst RH, Rogel N, Slyper M, Waldman J, Sud M, Andrews E, Velonias G, Haber AL, Jagadeesh K, Vickovic S, Yao J, Stevens C, Dionne D, Nguyen LT, Villani AC, Hofree M, Creasey EA, Huang H, Rozenblatt-Rosen O, Garber JJ, Khalili H, Desch AN, Daly MJ, Ananthakrishnan AN, Shalek AK, Xavier RJ, Regev A
Cell 2019 Jul 25;178(3):714-730.e22
Cell 2019 Jul 25;178(3):714-730.e22
CD103 and Intratumoral Immune Response in Breast Cancer.
Wang ZQ, Milne K, Derocher H, Webb JR, Nelson BH, Watson PH
Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Dec 15;22(24):6290-6297
Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Dec 15;22(24):6290-6297
Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer.
Wick DA, Webb JR, Nielsen JS, Martin SD, Kroeger DR, Milne K, Castellarin M, Twumasi-Boateng K, Watson PH, Holt RA, Nelson BH
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Mar 1;20(5):1125-34
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Mar 1;20(5):1125-34
Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer.
Milne K, Barnes RO, Girardin A, Mawer MA, Nesslinger NJ, Ng A, Nielsen JS, Sahota R, Tran E, Webb JR, Wong MQ, Wick DA, Wray A, McMurtrie E, Köbel M, Kalloger SE, Gilks CB, Watson PH, Nelson BH
PloS one 2008;3(10):e3409
PloS one 2008;3(10):e3409
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 1 Immunohistochemical analysis of serous ovarian tumors showing cases with high (left) and low (right) scores for the following markers: (A,B) CD20; (C,D) CD3; (E,F) CD4; (G,H) CD8; (I,J) MHC Class I; and (K,L) MHC Class II.
